Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial-Reference-Cited by-同舟云学术

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial

Published:2018-09-07 Issue:9 Volume:13 Page:e0203054
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Harrison Stephen A.,Dennis Andrea^ORCID,Fiore Martine M.,Kelly Matt D.,Kelly Catherine J.,Paredes Angelo H.,Whitehead Jennifer M.,Neubauer Stefan,Traber Peter G.,Banerjee Rajarshi

Funder

Galectin Therapeutics Inc.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;N Chalasani;Hepatology,2012

2. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle- aged population utilizing ultrasound and liver biopsy: a prospective study;CD Williams;Gastroenterology,2011

3. The natural history of non-alcoholic fatty liver disease;S Caldwell;Dig Dis Sci,2010

4. Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?;M Rinella;Hepatology,2011

5. When galectins recognize glycans: from biochemistry to physiology and back again;S Di Lella;Biochemistry,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH);Scientific Reports;2024-07-24

2. Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta‐analysis;Journal of Gastroenterology and Hepatology;2024-04-16

3. Pectin: Health-promoting properties as a natural galectin-3 inhibitor;Glycoconjugate Journal;2024-04

4. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents;Journal of Materials Chemistry B;2024

5. The Role of the Multiparametric MRI LiverMultiScanTM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis;Cancers;2023-10-05